Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. | J Food Drug Anal | 2025 | 41525198 | PubTator, text mining | PubMed |
| A Rare Case of Congenital Glucose Galactose Malabsorption Due to SLC5A1 Mutation. | Cureus | 2025 | 41510412 | PubTator, text mining | PubMed |
| Orexinergic pathway as a potential therapeutic candidate for the modulation of glucose homeostasis. | Front Physiol | 2025 | 41438219 | PubTator, text mining | PubMed |
| Pharmacological mechanisms and clinical applications between SGLT1 and SGLT2 inhibitors in type 2 diabetes and diabetic kidney disease: An analytic review. | Biomed Pharmacother | 2025 | 41317484 | PubTator, text mining | PubMed |
| THE INCIDENCE OF URINARY TRACT INFECTION AMONG PATIENTS TREATED WITH VARIABLE DOSES OF DAPAGLIFLOZIN: A COMPARATIVE STUDY. | Georgian Med News | 2025 | 41314192 | PubTator, text mining | PubMed |
| Molecular mechanisms and computational insights into human SGLTs: advancing toward selective SGLT1 inhibition. | Front Mol Biosci | 2025 | 41234538 | PubTator, text mining | PubMed |
| Dexamethasone enhances intestinal glucose absorption and TMPRSS2 expression with implications for hyperglycaemia and infection risk. | Sci Rep | 2025 | 41184395 | PubTator, text mining | PubMed |
| Engineering hope: tissue-engineered intestine as a breakthrough for pediatric short bowel syndrome. | Ann Med Surg (Lond) | 2025 | 41181438 | PubTator, text mining | PubMed |
| Inhibitory Effect of Boesenbergia rotunda and Its Major Flavonoids, Pinostrobin and Pinocembrin on Carbohydrate Digestive Enzymes and Intestinal Glucose Transport in Caco-2 Cells. | Int J Mol Sci | 2025 | 41155450 | PubTator, text mining | PubMed |
| Oral absorption mechanisms of Astragalus polysaccharides and potential as an excipient to increase the absorption of flavonoids. | Int J Biol Macromol | 2025 | 41033508 | PubTator, text mining | PubMed |
| Congenital Glucose-Galactose Malabsorption Presenting as Hypertriglyceridemia and Medullary Nephrocalcinosis. | Pediatr Rep | 2025 | 40981014 | PubTator, text mining | PubMed |
| Multi-disease transcriptomic analysis of sex hormone genes reveals a novel prognostic model for thyroid cancer with breast cancer correlations. | Front Oncol | 2025 | 40963858 | PubTator, text mining | PubMed |
| Comparative effects of continuous glucose monitoring-informed and traditional interval-based carbohydrate refueling protocols on endurance exercise responses: an exploratory study. | J Int Soc Sports Nutr | 2025 | 40957601 | PubTator, text mining | PubMed |
Whole genome transcriptional analysis of intestinal biopsies and blood cells indicate genes involved in antioxidant defense systems, amino acid metabolism and antigen presentation in the pathogenesis of celiac disease. | BMC Med | 2025 | 40883722 | PubTator, text mining | PubMed |
| The Adipose Tissue-Derived Secretome (ADS) in Obesity Uniquely Regulates the Na-Glucose Transporter SGLT1 in Intestinal Epithelial Cells. | Cells | 2025 | 40862720 | PubTator, text mining | PubMed |
| Screening of SGLT2 inhibitors based on virtual screening and cellular experiments. | Sci Rep | 2025 | 40858733 | PubTator, text mining | PubMed |
| Spatial and electronic features driving SGLT1/2 selectivity: a combined molecular dynamics and quantum mechanics study. | Phys Chem Chem Phys | 2025 | 40855836 | PubTator, text mining | PubMed |
| Association between antidiabetic drug targets and psychiatric disorders. | Schizophrenia (Heidelb) | 2025 | 40854907 | PubTator, text mining | PubMed |
| Botanical Antinutrients as Natural Modulators of Postprandial Hyperglycemia and Hyperlipidemia: A Narrative Review. | Phytother Res | 2025 | 40851438 | PubTator, text mining | PubMed |
| Exploring the disconnect: mechanisms underpinning the absence of physical function improvement with SGLT2 inhibitors. | Front Syst Biol | 2025 | 40810125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=5